Posted on

How Does Phosphate Binder Type Affect the Heart in Hemodialysis?

Loading

“Trial compared calcium-based vs non-calcium-based binders.

Non-calcium-based phosphate binders weren’t any better at reducing cardiovascular events than calcium-based binders in dialysis patients, the LANDMARK trial determined.

In the open-label randomized trial of over 2,300 Japanese patients on hemodialysis, there were no significant differences in composite cardiovascular events between the lanthanum carbonate group versus the calcium carbonate group (HR 1.11, 95% CI 0.88-1.41, P=0.37), reported Hiroaki Ogata, MD, of Showa University Northern Yokohama Hospital in Kanagawa, Japan, and colleagues.”

Read more, here.

Loading
Posted on

Why eGFR-reporting change helps tackle kidney disease inequities

Loading

“Structural racism in health care is real, and three ways its manifestation can be seen and measured are in the treatment and health outcomes for patients with kidney disease and, ultimately, the likelihood that they will receive a lifesaving transplant.

“Unfortunately, the facts are incontrovertible,” said Paul Palevsky, MD, president of the National Kidney Foundation (NKF). “People who identify as Black, Hispanic, Native American, Native Hawaiian and Pacific Islander are more likely to develop kidney disease, disproportionately progress to kidney failure, are less likely to be treated with home dialysis, and are much less likely to be referred, listed and receive a kidney transplant.” 

Dr. Palevsky made his remarks while delivering his presidential address at the NKF’s 2021 Spring Clinical Meetings, held virtually this year due to the pandemic. His talk was followed by a keynote presentation from AMA Chief Health Equity Officer Aletha Maybank, MD, MPH.”

Read full article, here.

Loading
Posted on

Chicago 6th grader gets kidney donation from woman who works at his school

Loading

“He had one kidney removed, but when the tumor kept coming back over the years, radiation treatments damaged his other kidney.

“It was pretty tough. I didn’t feel well,” he said. “I’d mostly go home and sit around.”

Ward Sexton said he and his wife Robyn set their sights on getting their son a new kidney and tried to find a donor.

“Robyn isn’t a blood match, I was ruled out, so we said, ‘We’ll ask friends,'” he said.

Last year, they wrote a letter asking those who may be interested to get a blood test to see if they were a match for Gavin. The email was forwarded and landed in the inbox of Ann Chiumino, who works in administration at Sacred Heart Academy, where Gavin is a student. The two did not know each other, but Chiumino said she felt the need to answer the call.”

Read the full story, here.

Loading
Posted on

PTC: Cancer Risks for Kidney Recipients

Loading

WHY AM I AT GREATER RISK OF DEVELOPING CANCER AFTER KIDNEY TRANSPLANT?

“All organ transplant recipients are at heightened risk of developing cancer after transplant. This is because although life-sustaining, long-term use of immunosuppressant drugs lowers the body’s ability to fend off certain cancers. When you are taking immunosuppressant drugs, your immune response is lowered, and this is what helps to prevent your body from rejecting your new kidney. It also means that your body is less able to recognize and destroy cancer cells or infections that can cause cancer.”

Read more on TRIO’s new Post-transplant Cancer Project (PTC) website, here.

Loading
Posted on

Prescription Discount and Assistance Resources

Loading

“Use the card to receive discounts on prescriptions while helping fight kidney disease at the same time. All medications are eligible for savings, including pet meds! Every time you save using the card, the National Kidney Foundation will receive a donation from Watertree Health, at no cost to you.”

Check out more information about the program, here.

Loading